Pulmatrix, Inc. Common Stock PULM
$1.38
+1.47%
at last close
Market Cap$5.04 million
P/E Ratio—
Div Yield—
Volume21.0K
52-Week Range
$1.16$9.37
Key Stats
- Today's Range
- $1.37 – $1.45
- 50-Day Range
- $1.16 – $2.49
- 52-Week Range
- $1.16 – $9.37
- Volume
- 21K shs
- Average Volume
- 27K shs
- Market Cap
- $5.04 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 42.23%
- Days to Cover
- 8.06
About Pulmatrix, Inc. Common Stock
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.